Cargando…
Rituximab-containing therapy for cold agglutinin disease: a retrospective study of 16 patients
Cold agglutinin disease (CAD) is a rare form of autoimmune haemolytic anaemia, and because of its rareness, there is no standard treatment for CAD patients. We retrospectively analysed the response to rituximab-containing therapy in CAD patients at our hospital. All patients received rituximab-conta...
Autores principales: | Jia, Ming-nan, Qiu, Yu, Wu, Yan-yan, Cai, Hao, Zhou, Dao-bin, Cao, Xin-xin, Li, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391738/ https://www.ncbi.nlm.nih.gov/pubmed/32728060 http://dx.doi.org/10.1038/s41598-020-69465-2 |
Ejemplares similares
-
Cold Agglutinin Disease
por: Gabbard, Amy P., et al.
Publicado: (2020) -
Total arch replacement for an aortic arch aneurysm with cold agglutinin disease after rituximab and plasmapheresis
por: Mitsuishi, Atsuyuki, et al.
Publicado: (2023) -
Pembrolizumab-Induced Cold Agglutinin Disease
por: Atiq, Osman, et al.
Publicado: (2020) -
Necrosis secondary to cold agglutinin disease
por: Nakagawa, Hiroaki, et al.
Publicado: (2022) -
Sutimlimab for the Treatment of Cold Agglutinin Disease
por: Berentsen, Sigbjørn
Publicado: (2023)